|
|
|
|
|
|
|
Articles by keyword
medicines
Provinces join forces to keep EU free-trade deal from upping drug costs
| 5-June-2012
The provincial premiers have undertaken a letter-writing campaign to demand compensation from the federal government for any increase in drug costs that might results from a free-trade agreement with Europe.
Canada’s other drug war
| 4-May-2012
There’s a debate raging over Canada’s intellectual property regime. If one side’s right, Canada stands to pay $2.8 billion more every year in drug costs while it undermines its generic-drug manufacturing sector.
After KORUS FTA, new pressures on the horizon
| 17-March-2012
As the South Korea-United States Free Trade Agreement (KORUS FTA) takes effects Thursday, some are expecting new trade pressures from the US, including moves to open the beef market. In particular, South Korea will be forced to sit down at the negotiating table if the US requests negotiations on beef.
US calls for additional FTA measures to ensure transparency in medicine pricing in Korea
| 7-March-2012
With just days left before the implementation of the US-Korea free trade agreement Washington is drawing attention to a little publicized area of the trade treaty, the part covering the pricing of medicine in Korea. The US says it wants more transparency; the Korean pharmaceutical industry says it wants to maintain control over pricing domestically.
TPP negotiators turn to pharmaceutical reimbursement
| 5-March-2012
Negotiations of the Transpacific Partnership Agreement (TPP) have turned to discussions of the pharmaceutical reimbursement chapter. This issue is highly controversial and represents a very recent shift in US trade policy.
ACTA : la dictature des marchés
| 23-February-2012
La lutte contre ACTA n’est pas seulement une question de liberté d’expression. Les dirigeants des pays riches de la planète et les multinationales démontrent avec ces accords que marchés = dictature = mort. À nous de montrer avec nos luttes qu’action = démocratie = vie.
Does EU/India free trade agreement spell the end of cheap drugs for poor countries?
| 10-February-2012
After four years of negotiations, campaigners fear India is about to sign a trade deal with the EU which will stop the flow of cheap life-saving drugs to the developing world 
Supporting the ongoing Global Week of Action on the EU-India FTA, Pauline Londeix of Act Up-Paris today confronted the European Commission for Trade, Karel de Gucht at a “Civil Society dialogue on Trade, Growth and development” at the European Commission. De Gucht reportedly leaves for India tomorrow for the EU-India Summit on 10th February 2012 where the E.C. is putting pressure on the Indian government to announce political trade-offs in the EU-India FTA. 
Nous appelons à une semaine d’action à travers le monde du 6 au 10 février 2012 sur l’accord de libre-échange entre l’Union Européenne et l’Inde. 
Fiji Network for Positive People believes that the Asia Pacific Network of People Living with HIV/AIDS meeting will be an opportune time to advocate for continuing availability of generic Anti Retro Viral treatment in the face of threats from Free Trade Agreement negotiations.
El Acuerdo de Asociación Trans Pacífico (TPP) y el monopolio de la industria farmacéutica
| 16-January-2012
Alejandra Alayza, coordinadora de la Red Peruana por una Globalización con Equidad, RedGE advirtió los peligros de la negociación del Acuerdo de Asociación Trans Pacífico (TPP) en el tema de la propiedad intelectual de los medicamentos.
AMCHAM interferes in domestic policies through FTA
| 7-January-2012
Under the Korea-US Free Trade Agreement (KORUS FTA), Korean civil servants would be excluded from the Health Insurance Review and Assessment Service (HIRA)’s process of price determination. Instead independent review procedures could be used to set prices for medicines and medical supplies. This has caused concern among health care groups who worry that multinational pharmaceutical companies could use the independent review procedure to change the Korean government’s medicine prices. 
As the 14th round of negotiations on the EU-India free trade agreement is held in Delhi, an NGO working in the health sector has urged the European Union not to push India to accept IP provisions in the deal 
DNP+ believes that IP should be completely be removed from the trade 
The scholars’ analysis concludes that the "US proposals, if adopted,
EEUU protege a sus farmacéuticas en nuevo TLC
| 26-October-2011
Textos que se debaten por estos días demuestran que de aprobarlos se generaría conflicto con la Comunidad Andina.
TPP: US TBT proposal (2011)
| 24-October-2011
Citizen Trade Campaign has released this proposed text from the US on technical barriers to trade relating to medical devices and pharmaceuticals under the Trans Pacific Partnership
Indian pharma industry to gain from free trade agreement with Gulf nations
| 13-October-2011
The Indian pharmaceuticals and chemicals industry will be among the biggest beneficiaries of a free trade agreement between the GCC and India, a leading banker in the region has said.
Perú: EEUU vuelve con sus exigencias
| 28-September-2011
El gobierno peruano dice que no cederá al pedido en materia de patentes o datos de prueba y mantendrá condiciones del TLC bilateral vigente. 
The Obama administration on Monday sought to allay concerns that the U.S. push for stronger drug patent protections in a Transpacific trade deal would raise the cost of life-saving treatments out of the reach of the region’s poor people. |
L’accord entre l’Union Européenne et l’Inde menace l’accès aux traitements en Afrique du Nord et au Moyen-Orient
| 12-April-2013
|
